Hubei Biocause Pharmaceutical Co., Ltd. (000627.SZ)
CNY 3.83
(-1.03%)
CNY 3.83
(-1.03%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | 1.21 Billion CNY | -96.12% |
| 2022 | 726.53 Million CNY | -5.19% |
| 2021 | 31.98 Billion CNY | 737.75% |
| 2020 | 2.93 Billion CNY | -67.48% |
| 2019 | 3.67 Billion CNY | -57.84% |
| 2018 | 2.7 Billion CNY | 16.8% |
| 2017 | 2.66 Billion CNY | 180.43% |
| 2016 | 2.86 Billion CNY | 1477.93% |
| 2015 | 423.78 Million CNY | 84.6% |
| 2014 | 213.03 Million CNY | 25190.68% |
| 2013 | -30.55 Million CNY | -101.01% |
| 2012 | 134.21 Million CNY | 753.61% |
| 2011 | -32.11 Million CNY | -113.71% |
| 2010 | 73.69 Million CNY | -2.18% |
| 2009 | 135.15 Million CNY | 149.4% |
| 2008 | 81.09 Million CNY | -58.07% |
| 2007 | 187 Million CNY | 18.89% |
| 2006 | 109.48 Million CNY | 81.88% |
| 2005 | 60.32 Million CNY | 10.06% |
| 2004 | 55.09 Million CNY | 2212.47% |
| 2003 | 2.37 Million CNY | -96.3% |
| 2002 | 64.11 Million CNY | -33.19% |
| 2001 | 95.08 Million CNY | 11.81% |
| 2000 | 87.76 Million CNY | 65.93% |
| 1999 | 51.72 Million CNY | 39.44% |
| 1998 | 36.71 Million CNY | -27.53% |
| 1997 | 51.18 Million CNY | 45.31% |
| 1996 | 35.22 Million CNY | 56.42% |
| 1995 | 22.52 Million CNY | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q3 | 1.57 Billion CNY | 27.27% |
| 2024 Q1 | 1.92 Billion CNY | -112.81% |
| 2024 Q2 | 1.24 Billion CNY | 914.84% |
| 2023 FY | - CNY | -96.12% |
| 2023 Q2 | 2.68 Billion CNY | -76.76% |
| 2023 Q4 | 1.18 Billion CNY | -76.4% |
| 2023 Q3 | 5.03 Billion CNY | 87.58% |
| 2023 Q1 | 11.55 Billion CNY | 126.02% |
| 2022 FY | - CNY | -5.19% |
| 2022 Q1 | 17.22 Billion CNY | 250.61% |
| 2022 Q2 | 5.91 Billion CNY | -65.64% |
| 2022 Q3 | 2.74 Billion CNY | -53.58% |
| 2022 Q4 | 5.11 Billion CNY | 86.15% |
| 2021 FY | - CNY | 737.75% |
| 2021 Q2 | 15.72 Billion CNY | 110.88% |
| 2021 Q3 | 4.81 Billion CNY | -69.37% |
| 2021 Q4 | 4.91 Billion CNY | 2.01% |
| 2021 Q1 | 7.45 Billion CNY | 280.95% |
| 2020 Q1 | 686.06 Million CNY | -62.86% |
| 2020 FY | - CNY | -67.48% |
| 2020 Q3 | 360.73 Million CNY | -67.22% |
| 2020 Q4 | 1.95 Billion CNY | 442.48% |
| 2020 Q2 | 1.1 Billion CNY | 60.4% |
| 2019 Q2 | 1.25 Billion CNY | -82.37% |
| 2019 FY | - CNY | -57.84% |
| 2019 Q1 | 7.09 Billion CNY | 85.87% |
| 2019 Q3 | 1.91 Billion CNY | 52.7% |
| 2019 Q4 | 1.84 Billion CNY | -3.37% |
| 2018 Q2 | 2.63 Billion CNY | -86.63% |
| 2018 Q3 | 1.49 Billion CNY | -43.39% |
| 2018 FY | - CNY | 16.8% |
| 2018 Q1 | 19.7 Billion CNY | 223.95% |
| 2018 Q4 | 3.81 Billion CNY | 156.07% |
| 2017 FY | - CNY | 180.43% |
| 2017 Q4 | 6.08 Billion CNY | 5.78% |
| 2017 Q3 | 5.75 Billion CNY | 24.39% |
| 2017 Q2 | 4.62 Billion CNY | -42.61% |
| 2017 Q1 | 8.05 Billion CNY | 91.82% |
| 2016 Q4 | 4.2 Billion CNY | 109.4% |
| 2016 Q3 | 2 Billion CNY | 84.49% |
| 2016 Q2 | 1.08 Billion CNY | -19.67% |
| 2016 Q1 | 1.35 Billion CNY | 158.93% |
| 2016 FY | - CNY | 1477.93% |
| 2015 FY | - CNY | 84.6% |
| 2015 Q3 | -11.38 Million CNY | -562.01% |
| 2015 Q4 | 522.71 Million CNY | 4692.06% |
| 2015 Q2 | 2.46 Million CNY | 114.26% |
| 2015 Q1 | -17.28 Million CNY | -105.87% |
| 2014 Q4 | 294.37 Million CNY | 1251.23% |
| 2014 Q3 | -25.57 Million CNY | -108.68% |
| 2014 Q2 | 294.72 Million CNY | 1216.0% |
| 2014 Q1 | -26.4 Million CNY | -31.26% |
| 2014 FY | - CNY | 25190.68% |
| 2013 Q2 | -2.67 Million CNY | 64.53% |
| 2013 Q1 | -7.53 Million CNY | -108.0% |
| 2013 Q4 | -20.11 Million CNY | 18.09% |
| 2013 Q3 | -24.56 Million CNY | -818.62% |
| 2013 FY | - CNY | -101.01% |
| 2012 FY | - CNY | 753.61% |
| 2012 Q1 | -6.94 Million CNY | 89.84% |
| 2012 Q2 | -7.51 Million CNY | -8.24% |
| 2012 Q3 | -12.58 Million CNY | -67.58% |
| 2012 Q4 | 94.25 Million CNY | 848.67% |
| 2011 Q2 | -20.82 Million CNY | -1906.38% |
| 2011 FY | - CNY | -113.71% |
| 2011 Q1 | -1.03 Million CNY | -103.56% |
| 2011 Q3 | -2.42 Million CNY | 88.36% |
| 2011 Q4 | -68.32 Million CNY | -2717.55% |
| 2010 Q1 | 28.84 Million CNY | -30.97% |
| 2010 FY | - CNY | -2.18% |
| 2010 Q4 | 29.18 Million CNY | 525.16% |
| 2010 Q3 | 4.66 Million CNY | -82.46% |
| 2010 Q2 | 26.62 Million CNY | -7.7% |
| 2009 Q1 | 8.57 Million CNY | 135.05% |
| 2009 FY | - CNY | 149.4% |
| 2009 Q2 | 31.82 Million CNY | 271.1% |
| 2009 Q3 | 12.94 Million CNY | -59.33% |
| 2009 Q4 | 41.78 Million CNY | 222.86% |
| 2008 Q4 | -24.46 Million CNY | -334.91% |
| 2008 FY | - CNY | -58.07% |
| 2008 Q3 | 10.41 Million CNY | -78.24% |
| 2008 Q1 | 26.07 Million CNY | -69.12% |
| 2008 Q2 | 47.87 Million CNY | 83.61% |
| 2007 FY | - CNY | 18.89% |
| 2007 Q2 | 27 Million CNY | 74.14% |
| 2007 Q3 | 6.62 Million CNY | -75.48% |
| 2007 Q4 | 84.44 Million CNY | 1175.39% |
| 2007 Q1 | 15.5 Million CNY | -70.22% |
| 2006 Q1 | 11.15 Million CNY | -50.8% |
| 2006 FY | - CNY | 81.88% |
| 2006 Q2 | 32.6 Million CNY | 192.42% |
| 2006 Q3 | 18.38 Million CNY | -43.62% |
| 2006 Q4 | 52.08 Million CNY | 183.31% |
| 2005 Q4 | 22.66 Million CNY | 168.42% |
| 2005 Q3 | 8.44 Million CNY | -49.54% |
| 2005 Q2 | 16.73 Million CNY | 15.71% |
| 2005 Q1 | 14.46 Million CNY | -58.34% |
| 2005 FY | - CNY | 10.06% |
| 2004 Q4 | 34.71 Million CNY | 266.73% |
| 2004 Q2 | 24.1 Million CNY | 2136.11% |
| 2004 Q1 | 1.07 Million CNY | 149.78% |
| 2004 FY | - CNY | 2212.47% |
| 2004 Q3 | 9.46 Million CNY | -60.73% |
| 2003 Q4 | -2.16 Million CNY | -202.49% |
| 2003 FY | - CNY | -96.3% |
| 2003 Q1 | 7.46 Million CNY | 483.34% |
| 2003 Q2 | 2.31 Million CNY | -68.96% |
| 2003 Q3 | 2.11 Million CNY | -8.87% |
| 2002 Q3 | 5.66 Million CNY | -67.87% |
| 2002 Q2 | 17.62 Million CNY | 670.56% |
| 2002 Q1 | 2.28 Million CNY | 0.0% |
| 2002 FY | - CNY | -33.19% |
| 2002 Q4 | 1.28 Million CNY | -77.4% |
| 2001 FY | - CNY | 11.81% |
| 2000 FY | - CNY | 65.93% |
| 1999 FY | - CNY | 39.44% |
| 1998 FY | - CNY | -27.53% |
| 1997 FY | - CNY | 45.31% |
| 1996 FY | - CNY | 56.42% |
| 1995 FY | - CNY | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| COFCO Capital Holdings Co., Ltd. | 2 Billion CNY | 39.287% |